Literature DB >> 30601883

Association Between Antidepressant Drug Use and Hip Fracture in Older People Before and After Treatment Initiation.

Jon Brännström1, Hugo Lövheim1, Yngve Gustafson1, Peter Nordström1.   

Abstract

Importance: Treatment with antidepressants has been associated with hip fracture. This association could restrict the treatment options, especially in older patients. Objective: To investigate the association between antidepressant drug treatment and hip fracture starting 1 year before the initiation of treatment. Design, Setting, and Participants: In this nationwide cohort study, 204 072 individuals in the Prescribed Drugs Register of Sweden's National Board of Health and Welfare aged 65 years or older who had a prescription of antidepressants filled between July 1, 2006, and December 31, 2011, were matched by birth year and sex to 1 control participant who was not prescribed antidepressants (for a total of 408 144 people in the register). Outcome data were collected from 1 year before to 1 year after the index date (date of prescription being filled). Data analysis was performed from July 1, 2005, to December 31, 2012. Exposures: First filled prescription of an antidepressant drug. Main Outcomes and Measures: Incident hip fractures occurring in the year before and year after initiation of antidepressant therapy were registered. Associations were investigated using multivariable conditional logistic regression models and flexible parametric models.
Results: Of the 408 144 people in the register who were included in the study, 257 486 (63.1%) were women, with a mean (SD) age of 80.1 (7.2) years. Antidepressant users sustained more than twice as many hip fractures than did nonusers in the year before and year after the initiation of therapy (2.8% vs 1.1% and 3.5% vs 1.3%, respectively, per actual incidence figures). In adjusted analyses, the odds ratios were highest for the associations between antidepressant use and hip fracture 16 to 30 days before the prescription was filled (odds ratio, 5.76; 95% CI, 4.73-7.01). In all separate analyses of age groups, of men and women, and of individual antidepressants, the highest odds ratios were seen 16 to 30 days before initiation of treatment, and no clear dose-response relationship was seen. Conclusions and Relevance: The present study found an association between antidepressant drug use and hip fracture before and after the initiation of therapy. This finding raises questions about the association that should be further investigated in treatment studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30601883      PMCID: PMC6440395          DOI: 10.1001/jamapsychiatry.2018.3679

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  6 in total

1.  Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review.

Authors:  Elena Dragioti; Marco Solmi; Angela Favaro; Paolo Fusar-Poli; Paola Dazzan; Trevor Thompson; Brendon Stubbs; Joseph Firth; Michele Fornaro; Dimitrios Tsartsalis; Andre F Carvalho; Eduard Vieta; Philip McGuire; Allan H Young; Jae Il Shin; Christoph U Correll; Evangelos Evangelou
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

2.  Evidence synthesis based on non-randomised studies-a critical review of studies leading to conclusions on fall risk properties of loop diuretics/beta-blockers.

Authors:  Susanna M Wallerstedt; Mikael Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  2019-10-10       Impact factor: 2.953

Review 3.  Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis.

Authors:  Renato de Filippis; Michele Mercurio; Giovanna Spina; Pasquale De Fazio; Cristina Segura-Garcia; Filippo Familiari; Giorgio Gasparini; Olimpio Galasso
Journal:  Healthcare (Basel)       Date:  2022-04-26

Review 4.  Postacute Management of Older Adults Suffering an Osteoporotic Hip Fracture: A Consensus Statement From the International Geriatric Fracture Society.

Authors:  Bernardo J Reyes; Daniel A Mendelson; Nadia Mujahid; Simon C Mears; Lauren Gleason; Kathleen K Mangione; Arvind Nana; Maria Mijares; Joseph G Ouslander
Journal:  Geriatr Orthop Surg Rehabil       Date:  2020-07-16

5.  Impact of age on optimal dose of antidepressants.

Authors:  Kenji Hashimoto
Journal:  EClinicalMedicine       Date:  2020-01-03

6.  Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study.

Authors:  E Clapham; R Bodén; J Reutfors; T Svensson; D Ramcharran; H Qiu; H Kieler; S Bahmanyar
Journal:  Acta Psychiatr Scand       Date:  2019-10-11       Impact factor: 6.392

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.